At the end of last week, Dr. Colleen Kelley said she was getting texts about every 10 minutes from colleagues whose ...
Data from both studies showcased the superiority of twice-yearly injectable, lenacapavir, compared to once-daily oral Truvada and background HIV incidence rates, prompting Gilead to unblind the ...